1. Home
  2. WKC vs AGIO Comparison

WKC vs AGIO Comparison

Compare WKC & AGIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo World Kinect Corporation

WKC

World Kinect Corporation

HOLD

Current Price

$22.76

Market Cap

1.4B

Sector

Energy

ML Signal

HOLD

Logo Agios Pharmaceuticals Inc.

AGIO

Agios Pharmaceuticals Inc.

HOLD

Current Price

$27.80

Market Cap

1.6B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
WKC
AGIO
Founded
1984
2007
Country
United States
United States
Employees
N/A
N/A
Industry
Oil Refining/Marketing
Biotechnology: Pharmaceutical Preparations
Sector
Energy
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.4B
1.6B
IPO Year
1994
2013

Fundamental Metrics

Financial Performance
Metric
WKC
AGIO
Price
$22.76
$27.80
Analyst Decision
Hold
Buy
Analyst Count
3
8
Target Price
$28.00
$37.63
AVG Volume (30 Days)
703.3K
708.3K
Earning Date
05-22-2026
05-15-2026
Dividend Yield
3.46%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$36,916,600,000.00
$43,011,000.00
Revenue This Year
$0.67
$75.68
Revenue Next Year
$5.28
$167.63
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$22.71
$22.24
52 Week High
$29.85
$46.00

Technical Indicators

Market Signals
Indicator
WKC
AGIO
Relative Strength Index (RSI) 24.20 46.37
Support Level N/A $26.48
Resistance Level $26.55 $29.49
Average True Range (ATR) 0.59 1.13
MACD -0.22 -0.17
Stochastic Oscillator 3.05 25.09

Price Performance

Historical Comparison
WKC
AGIO

About WKC World Kinect Corporation

World Kinect Corp is an energy management company involved in providing supply fulfillment, energy procurement advisory services, and transaction and payment management solutions to commercial and industrial customers. It sells and delivers liquid fuels, natural gas, electricity, renewable energy, and other sustainability solutions. The company operates in three reportable segments consisting of aviation, land, and marine. The company earns the majority of its revenue from the Aviation segment.

About AGIO Agios Pharmaceuticals Inc.

Agios Pharmaceuticals Inc is a biopharmaceutical company focused on the field of cellular metabolism to create differentiated medicines for rare diseases, with a focus on classical hematology. The company's primary focus is to develop potentially transformative small-molecule medicines. Its product candidate, Pyrukynd (mitapivat), is an activator of both wild-type and mutant pyruvate kinase enzymes, developed for the treatment of hemolytic anemias. The other drug candidates in its pipeline include Tebapivat (PK activator), being developed as a potential treatment for MDS-associated anemia and sickle cell disease, AG-181 (PAH stabilizer), AG-236, and others.

Share on Social Networks: